Lactobacillus rhamnosus UA260 strain and application thereof in regulating blood uric acid
The invention relates to the technical field of microorganisms, and discloses a lactobacillus rhamnosus UA260 strain and application thereof in regulating blood uric acid, the lactobacillus rhamnosus UA260 strain is preserved in China Center for Type Culture Collection of Microorganisms of Guangdong Province on March 10, 2023, and the preservation number is GDMCC No: 63250. The lactobacillus rhamnosus UA260 can be used for preparing food for reducing blood uric acid or medicine for reducing blood uric acid, and the lactobacillus rhamnosus UA260 obtained by screening is relatively good in safety, regulates and improves the intestinal microecological balance of a host, exerts the beneficial effects of the lactobacillus rhamnosus UA260 and generates an exact healthy effect; in-vitro and animal tests show that the traditional Chinese medicine composition has a relatively strong function of reducing uric acid in blood..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 03. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LIU ZHIGANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 |
|---|
| Patentnummer: |
CN116987617 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA019068220 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA019068220 | ||
| 003 | DE-627 | ||
| 005 | 20240126103910.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240126s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA019068220 | ||
| 035 | |a (EPA)CN116987617 | ||
| 035 | |a (EPA)88525439 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LIU ZHIGANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lactobacillus rhamnosus UA260 strain and application thereof in regulating blood uric acid |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 | ||
| 520 | |a The invention relates to the technical field of microorganisms, and discloses a lactobacillus rhamnosus UA260 strain and application thereof in regulating blood uric acid, the lactobacillus rhamnosus UA260 strain is preserved in China Center for Type Culture Collection of Microorganisms of Guangdong Province on March 10, 2023, and the preservation number is GDMCC No: 63250. The lactobacillus rhamnosus UA260 can be used for preparing food for reducing blood uric acid or medicine for reducing blood uric acid, and the lactobacillus rhamnosus UA260 obtained by screening is relatively good in safety, regulates and improves the intestinal microecological balance of a host, exerts the beneficial effects of the lactobacillus rhamnosus UA260 and generates an exact healthy effect; in-vitro and animal tests show that the traditional Chinese medicine composition has a relatively strong function of reducing uric acid in blood. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a A23L: Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses a21d or a23b-a23j; their preparation or treatment, e.g. cooking, modification of nutritive qualities, physical treatment (shaping or working, not fully covered by this subclass, a23p); preservation of foods or foodstuffs, in general | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG QIANXU |4 aut | |
| 700 | 0 | |a ZHONG HAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 03. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:03 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88525439/publication/CN116987617A1?q=CN116987617 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 03 |c 11 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 03 |c 11 | ||